You are here

  • Home
  • Archive
  • Volume 7, Issue 2
  • Long-term safety and effectiveness of canakinumab therapy in patients with cryopyrin-associated periodic syndrome: results from the β-Confident Registry

Article metrics

Article menu

Download PDFPDF

XML
Autoinflammatory disorders
Original research
Long-term safety and effectiveness of canakinumab therapy in patients with cryopyrin-associated periodic syndrome: results from the β-Confident Registry

 

Online download statistics by month:

Online download statistics by month: May 2021 to March 2024

AbstractFullPdf
May 202128327598
Jun 202114113478
Jul 202110610153
Aug 2021878635
Sep 2021817931
Oct 2021464465
Nov 2021636236
Dec 2021404016
Jan 2022636415
Feb 2022626416
Mar 2022474619
Apr 2022504819
May 2022656331
Jun 2022525616
Jul 2022505012
Aug 202211111111
Sep 2022788028
Oct 2022636315
Nov 2022424414
Dec 2022323210
Jan 2023424420
Feb 2023686932
Mar 2023474717
Apr 2023323021
May 2023404261
Jun 2023393710
Jul 2023615524
Aug 2023394015
Sep 2023514614
Oct 2023484712
Nov 2023504711
Dec 2023898120
Jan 2024342715
Feb 2024444324
Mar 202410510390
Total235123001004